Centro di Prevenzione Senologica (CPS), P.O. Marzana, ULSS 20, Piazza L. Lambranzi, 1, 37142, Marzana, Verona, Italy.
Radiol Med. 2011 Feb;116(1):84-91. doi: 10.1007/s11547-010-0606-0. Epub 2010 Oct 27.
The authors sought to assess the role of arbitration by a third reader of discordant double readings to reduce the rate of recalls to diagnostic assessment.
A consecutive series of 7,660 double readings of screening examinations were considered. Discordant recalls were arbitrated by an expert reader (negative/positive). Diagnostic assessment was performed irrespective of arbitration results, and its outcome was used as reference standard for the study purpose. Assuming that negative arbitration would deny recall, its impact was assessed in terms of reduced recall rate and reduced cancer detection rate. Cost analysis of introducing arbitration was performed according to these results.
Recalls at double reading were 528 (6.8%), of which 230 (43.5%) were concordant and 298 (56.5%) were discordant. The latter underwent arbitration, which was negative in 216 (72.4%) and positive in 82 (27.6%) cases, respectively. Overall, 49 cancers were detected (6.39 ‰ screened, 9.2% recalled): 43 cancers were detected among concordant (5.6 ‰ screened, 18.6% concordant) and six among discordant recalls (0.7 ‰ screened, 2.0% discordant). Six cancers were observed among arbitrated cases: five (6%) in positive and one (4.6 ‰) in negative arbitrations. Negative arbitration would have spared 216 assessment procedures (2.8% absolute, 40.9% relative reduction of recall rate) while missing one cancer case (0.13 ‰ absolute, 2.0% relative reduction of cancer detection rate). Arbitration cost was 74 euro, whereas 216 spared assessment procedures would have cost 14,558.4-23,346 euro.
Arbitration is a cost-effective procedure that could be employed as a first measure to counterbalance excess recall rate observed in a double-reading scenario.
作者旨在评估由第三方读者仲裁不一致的双重阅读结果以减少召回进行诊断评估的比例。
对连续 7660 例筛查检查的双重阅读进行了研究。由专家读者(阴性/阳性)对不一致的召回进行仲裁。无论仲裁结果如何,均进行诊断评估,其结果作为本研究目的的参考标准。假设阴性仲裁将否认召回,根据降低召回率和降低癌症检出率来评估其影响。根据这些结果,对引入仲裁的成本进行了分析。
双重阅读时的召回率为 528 例(6.8%),其中 230 例(43.5%)为一致性召回,298 例(56.5%)为不一致性召回。后者接受仲裁,分别有 216 例(72.4%)和 82 例(27.6%)为阴性和阳性结果。总的来说,共检出 49 例癌症(筛查检出率 6.39‰,召回检出率 18.6%):43 例在一致性召回中检出(筛查检出率 5.6‰,召回检出率 18.6%),6 例在不一致性召回中检出(筛查检出率 0.7‰,召回检出率 2.0%)。在仲裁病例中观察到 6 例癌症:阳性仲裁中有 5 例(6%),阴性仲裁中有 1 例(4.6‰)。阴性仲裁本可避免 216 次评估程序(绝对减少率 2.8%,相对减少率 40.9%),但会漏诊 1 例癌症(绝对减少率 0.13‰,相对减少率 2.0%)。仲裁成本为 74 欧元,而避免 216 次评估程序的成本将为 14558.4-23346 欧元。
仲裁是一种具有成本效益的方法,可作为平衡双重阅读中观察到的过高召回率的首要措施。